{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:08:42Z","timestamp":1788930522203,"version":"build-2803163510"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T00:00:00Z","timestamp":1781740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00595-026-03375-0","type":"journal-article","created":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T12:27:54Z","timestamp":1781785674000},"page":"2370-2377","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cisplatin versus carboplatin as adjuvant chemotherapy for completely resected non-small cell lung cancer: a multicenter retrospective cohort study"],"prefix":"10.1007","volume":"56","author":[{"given":"Masatsugu","family":"Hamaji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ozu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Kohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Sumitomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamoru","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehisa","family":"Fukada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megumi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Kumaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyofumi Fengshi","family":"Chen-Yoshikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,18]]},"reference":[{"key":"3375_CR1","volume-title":"Guidelines for diagnosis and treatment of lung cancer","author":"Japan Lung Cancer Society","year":"2023","unstructured":"Japan Lung Cancer Society. Guidelines for diagnosis and treatment of lung cancer. Tokyo: Kanehara & Co., Ltd.; 2023. (in Japanese)."},{"key":"3375_CR2","unstructured":"National Comprehensive Cancer Network. Non\u2013Small Cell Lung Cancer. Version 2024.1. NCCN Clinical Practice Guidelines in Oncology. Fort Washington (PA): National Comprehensive Cancer Network. 2024. Available from: Accessed April 2024. . Accessed April 2024. https:\/\/www.nccn.org. Accessed April 2024."},{"issue":"4","key":"3375_CR3","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.annonc.2022.12.009","volume":"34","author":"PE Postmus","year":"2023","unstructured":"Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, et al. Early and locally advanced non\u2013small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2023;34(4):339\u201357.","journal-title":"Ann Oncol"},{"issue":"21","key":"3375_CR4","doi-asserted-by":"publisher","first-page":"3552","DOI":"10.1200\/JCO.2007.13.9030","volume":"26","author":"P JP Pignon","year":"2008","unstructured":"Pignon P JP, Tribodet H, Scagliotti GV, Douillard JY, Shepherd FA, Stephens RJ, et al. Lung adjuvant cisplatin evaluation: a pooled analysis by the LACE Collaborative Group. J Clin Oncol. 2008;26(21):3552\u20139.","journal-title":"J Clin Oncol"},{"issue":"11","key":"3375_CR5","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/jnci\/djk196","volume":"99","author":"A Ardizzoni","year":"2007","unstructured":"Ardizzoni A, Boni L, Tiseo M, Fossella FV, Schiller JH, Paesmans M, Smit EF, et al. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non\u2013small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst. 2007;99(11):847\u201357.","journal-title":"J Natl Cancer Inst"},{"key":"3375_CR6","first-page":"30","volume":"43","author":"GY Ho","year":"2016","unstructured":"Ho GY, Woodward N, Coward JIG. Cisplatin versus carboplatin: comparative review of efficacy and toxicity. Cancer Treat Rev. 2016;43:30\u20139.","journal-title":"Cancer Treat Rev"},{"key":"3375_CR7","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1016\/j.lungcan.2019.07.010","volume":"135","author":"F Griesinger","year":"2019","unstructured":"Griesinger F, Korol EE, Kayaniyil S, Varol N, Ebner T, Goring SM. Efficacy and safety of first-line carboplatin- versus cisplatin-based chemotherapy for patients with non\u2013small-cell lung cancer: a systematic literature review and meta-analysis. Lung Cancer. 2019;135:196\u2013204.","journal-title":"Lung Cancer"},{"issue":"6","key":"3375_CR8","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1007\/s00280-008-0711-0","volume":"61","author":"V Launay-Vacher","year":"2008","unstructured":"Launay-Vacher V, Rey JB, Isnard-Bagnis C, Deray G, Daouphars M. Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy. Cancer Chemother Pharmacol. 2008;61(6):903\u20139.","journal-title":"Cancer Chemother Pharmacol"},{"key":"3375_CR9","first-page":"47","volume":"296","author":"Z Duan","year":"2018","unstructured":"Duan Z, Cai G, Li J, Chen X. Impact of aging on platinum-related toxicity in cancer patients: a systematic review. Chemico-Biol Interact. 2018;296:47\u201354.","journal-title":"Chemico-Biol Interact"},{"key":"3375_CR10","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1470-2045(06)70804-X","volume":"7","author":"JY Douillard","year":"2006","unstructured":"Douillard JY, Rosell R, De Lena M, Riggi M, Hurteloup P, Mahe MA. Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB\u2013IIIA non\u2013small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial. Lancet Oncol. 2006;7:719\u201327.","journal-title":"Lancet Oncol"},{"key":"3375_CR11","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1056\/NEJMoa043623","volume":"352","author":"T Winton","year":"2005","unstructured":"Winton T, Livingston R, Johnson D, Rigas J, Johnston M, Butts C, et al. Vinorelbine plus cisplatin vs observation in resected non\u2013small-cell lung cancer. N Engl J Med. 2005;352:2589\u201397.","journal-title":"N Engl J Med"},{"issue":"11","key":"3375_CR12","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/jnci\/djk196","volume":"99","author":"A Ardizzoni","year":"2007","unstructured":"Ardizzoni A, Boni L, Tiseo M, Fossella FV, Schiller JH, Paesmans M, et al. Cisplatin- versus carboplatin-based chemotherapy in first-line treatment of advanced non\u2013small-cell lung cancer: an individual patient data meta-analysis. J Natl Cancer Inst. 2007;99(11):847\u201357.","journal-title":"J Natl Cancer Inst"},{"key":"3375_CR13","doi-asserted-by":"publisher","first-page":"3852","DOI":"10.1200\/JCO.2004.02.109","volume":"22","author":"K Hotta","year":"2004","unstructured":"Hotta K, Matsuo K, Ueoka H, Kiura K, Tabata M, Tanimoto M. Meta-analysis of randomized clinical trials comparing cisplatin to carboplatin in patients with advanced non\u2013small-cell lung cancer. J Clin Oncol. 2004;22:3852\u20139.","journal-title":"J Clin Oncol"},{"key":"3375_CR14","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.lungcan.2019.11.009","volume":"141","author":"K Kubota","year":"2020","unstructured":"Kubota K, Kunitoh H, Seto T, Shimada N, Tsuboi M, Ohhira T, et al. Randomized phase II trial of adjuvant chemotherapy with docetaxel plus cisplatin versus paclitaxel plus carboplatin in patients with completely resected non-small cell lung cancer: TORG 0503. Lung Cancer. 2020;141:32\u20136.","journal-title":"Lung Cancer"},{"issue":"1","key":"3375_CR15","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00280-020-04104-1","volume":"86","author":"SI Fukumoto","year":"2020","unstructured":"Fukumoto SI, Oizumi S, Harada M, Sukoh N, Nakano K, Fuke S, et al. A randomized phase II trial of cisplatin plus gemcitabine versus carboplatin plus gemcitabine in patients with completely resected non-small cell lung cancer: Hokkaido Lung Cancer Clinical Study Group Trial (HOT0703). Cancer Chemother Pharmacol. 2020;86(1):117\u201327.","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"3375_CR16","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s12957-020-02041-0","volume":"18","author":"S Takashima","year":"2020","unstructured":"Takashima S, Imai K, Atari M, Matsuo T, Nakayama K, Sato Y, et al. Clinical benefits of adjuvant chemotherapy with carboplatin and gemcitabine in patients with non-small cell lung cancer: a single-center retrospective study. World J Surg Oncol. 2020;18(1):263.","journal-title":"World J Surg Oncol"},{"key":"3375_CR17","doi-asserted-by":"publisher","first-page":"5043","DOI":"10.1200\/JCO.2008.16.4855","volume":"26","author":"GM Strauss","year":"2008","unstructured":"Strauss GM, Herndon JE 2nd, Maddaus MA, Johnstone DW, Johnson EA, Harpole DH Jr, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non-small-cell lung cancer: CALGB 9633 with the Cancer and Leukemia Group B, Radiation Therapy Oncology Group, and North Central Cancer Treatment Group Study Groups. J Clin Oncol. 2008;26:5043\u201351.","journal-title":"J Clin Oncol"},{"key":"3375_CR18","doi-asserted-by":"publisher","first-page":"3138","DOI":"10.1200\/JCO.2009.27.6204","volume":"28","author":"E Felip","year":"2010","unstructured":"Felip E, Rosell R, Maestre JA, Rodr\u00edguez-Paniagua JM, Mor\u00e1n T, Astudillo J, et al. Preoperative chemotherapy plus surgery versus surgery plus adjuvant chemotherapy versus surgery alone in early-stage non-small-cell lung cancer: a randomized controlled trial. J Clin Oncol. 2010;28:3138\u201345.","journal-title":"J Clin Oncol"},{"key":"3375_CR19","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1007\/s00595-024-02987-8","volume":"55","author":"M Takahashi","year":"2025","unstructured":"Takahashi M, Aoyama A, Hamaji M, Sozu T, Kobayashi M, Nakagawa T, et al. Clinical significance of the preoperative prognostic nutritional index in patients with resectable non-small cell lung cancer: a multicenter study. Surg Today. 2025;55:918\u201329.","journal-title":"Surg Today"},{"key":"3375_CR20","doi-asserted-by":"crossref","unstructured":"Shintani Y, Yamamoto H, Sato Y, Inoue M, Asakura K, Ito H et al. Impact of the COVID-19 pandemic on thoracic surgery volume in Japan: an analysis of the National Clinical Database. Surg Today. 2025 Oct 27.","DOI":"10.1007\/s00595-025-03156-1"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03375-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-026-03375-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03375-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:35:38Z","timestamp":1788928538000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-026-03375-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,18]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3375"],"URL":"https:\/\/doi.org\/10.1007\/s00595-026-03375-0","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,18]]},"assertion":[{"value":"14 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We have no conflict of interest to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}